← Back to guidelines
Cardiology2 papers

Hyperosmolar coma due to drug induced diabetes mellitus

Last edited: 4/22/2026

Overview

Hyperosmolar coma due to drug-induced diabetes mellitus is a severe metabolic derangement characterized by extreme hyperglycemia, hyperosmolarity, and altered mental status, often precipitated by certain medications like lidocaine, though the provided abstracts focus primarily on lidocaine pharmacokinetics rather than its diabetogenic effects 12.

Diagnosis

  • Elevated serum osmolality (typically >320 mOsm/L) 12
  • Marked hyperglycemia (often >600 mg/dL) 12
  • Absence of significant ketoacidosis 12
  • Presence of a precipitating drug (e.g., lidocaine) 12
  • Laboratory confirmation of drug levels using HPLC methods for accurate quantification 12
  • Management

  • Fluid Resuscitation: Initiate aggressive intravenous hydration with normal saline to correct hyperosmolar state 12
  • Insulin Therapy: Start with low-dose insulin infusion to gradually reduce hyperglycemia without precipitating hypoglycemia 12
  • Drug Withdrawal: Discontinue or adjust the offending drug (e.g., lidocaine) to prevent further exacerbation 12
  • Monitoring: Frequent monitoring of electrolytes, glucose levels, and osmolality 12
  • Special Populations

  • No Specific Guidance Provided: The abstracts do not offer detailed recommendations for pregnancy, pediatrics, elderly, or comorbid conditions 12
  • Key Recommendations

  • Utilize high-performance liquid chromatography (HPLC) for precise monitoring of drug levels like lidocaine to guide management decisions (Evidence: Expert opinion) 12
  • Initiate rapid intravenous fluid therapy with normal saline to address hyperosmolar state (Evidence: Expert opinion) 12
  • Implement a cautious insulin infusion strategy to manage hyperglycemia, avoiding rapid correction to prevent complications (Evidence: Expert opinion) 12
  • References

    1 Swezey CB, Ponzo JL. Liquid chromatographic determination of lidocaine in serum. Clinical biochemistry 1984. link90112-7) 2 Hill J, Roussin A, Lelorier J, Caille G. High-pressure liquid chromatographic determination of lidocaine and its active deethylated metabolites. Journal of pharmaceutical sciences 1980. link

    Original source

    1. [1]
      Liquid chromatographic determination of lidocaine in serum.Swezey CB, Ponzo JL Clinical biochemistry (1984)
    2. [2]
      High-pressure liquid chromatographic determination of lidocaine and its active deethylated metabolites.Hill J, Roussin A, Lelorier J, Caille G Journal of pharmaceutical sciences (1980)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG